NCT03041714

Brief Summary

Background: Essential tremor is when a person has tremor, but no other neurological symptoms. Dystonic tremor is when a person also has dystonia. Dystonia is a condition in which muscle contraction causes changes in posture. Researchers do not fully know what areas of the brain cause these tremors, or how the types differ. They also do not know what tests can identify the differences. Objective: To look at differences between essential tremor and dystonic tremor. Eligibility: People ages 18 and older with or without tremor Design: Participants will be screened with medical history, physical exam, and urine tests. Those with tremor will complete questionnaires about how tremor affects them. The screening and study visits can be done on the same day or on separate days. Participants will have 1 or 2 study visits. These include magnetic resonance imaging (MRI) and tremor testing. For MRI, participants will lie on a table that slides in and out of a cylinder that takes pictures. Sensors on the skin measure breathing, heart rate, and muscle activity. This takes about 2 hours. Tremor testing will include transcranial magnetic stimulation (TMS), electrical stimulation of the fingers, doing a movement task, and recording of tremor movements. For TMS, two wire coils will be held on the scalp and a brief magnetic field will be produced. A brief electrical current will pass through the coils. For the other tests, small sticky pad electrodes will be put on the skin. Participants will move their hand when they hear a sound. They will get weak electrical shocks to their fingers. These tests will take 3-4 hours. Participants can take part in either or both parts of the study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 2, 2017

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 3, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

April 7, 2017

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 22, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 22, 2018

Completed
Last Updated

August 1, 2018

Status Verified

March 1, 2018

Enrollment Period

12 months

First QC Date

February 2, 2017

Last Update Submit

July 31, 2018

Conditions

Keywords

Essential TremorCervical DystoniaHand DystoniaNeurophysiologyDystonic Tremor

Outcome Measures

Primary Outcomes (1)

  • The various neurophysiological results including the data from TMS experiment, tremor analysis, threshold of temporal discrimination, ballistic movement and MRI experiment. These results will be compared between HVs and patients group.

    2 years

Study Arms (3)

Normal volunteers

people who are healthy and without tremor

Essential tremor

Patients with essential tremor

Dystonic tremor

patient with tremor who also have dystonia

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients will be referred to NIH or may refer themselves from all over the United States.

You may qualify if:

  • Tremor Subjects:
  • Must be 18 years or older
  • Fulfill the diagnostic criteria of essential tremor, pure dystonic tremor and tremor associated dystonia, as defined by the Consensus Statement of the Movement Disorder Society on Tremor, 1998. We will recruit patients displaying hand tremors in each group as the follows:
  • Hand tremor patients in ET group.
  • Dystonic hand tremor patients in pDT group.
  • Cervical dystonia (CD) patients or spasmodic dysphonia and hand tremor without clinical evidence of hand dystonia in TAWD group.
  • Ability to give informed consent.
  • Ability to comply with all study procedures, based on the judgment by the investigator(s).
  • Agree to not drink caffeine or alcohol for 48 hours before participating in the protocol.
  • Healthy Volunteers:
  • Must be 18 years or older
  • Absence of dystonia or other neurological disorder with any effect on the motor or sensory systems.
  • Ability to give informed consent.
  • Ability to comply with all study procedures, based on the judgment by the investigator(s).
  • Agree to not drink caffeine or alcohol for 48 hours before participating in the protocol.

You may not qualify if:

  • Patients:
  • Botulinum toxin treatment \< 3 months prior to visit.
  • Employees and/or staff of NINDS
  • Has used illegal drugs within the past 6 months based on history. The intent is to exclude those with drug use that may affect study results. Participants who appear to be intoxicated at the time of testing will be rescheduled.
  • Has more than 7 alcoholic drinks a week in the case of a woman and 14 alcoholic drinks a week in the case of a man.
  • Abnormal findings on neurologic exam (other than tremor and dystonia in patient group)
  • Has had a brain tumor, a stroke, head trauma, epilepsy or a history of seizures.
  • Has major depression or any major mental disorders (axis I disorders)
  • Has a neurologic disorder other than tremor or dystonia
  • Has had a head injury where there was a loss of consciousness for more than a few seconds.
  • Currently taking primidone, anticholinergics or benzodiazepines.
  • Healthy Volunteers:
  • Employees and/or staff of NINDS
  • Has used illegal drugs within the past 6 months based on history. The intent is to exclude those with drug use that may affect study results. Participants who appear to be intoxicated at the time of testing will be rescheduled.
  • Has more than 7 alcoholic drinks a week in the case of a woman and 14 alcoholic drinks a week in the case of a man.
  • +12 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institutes of Health Clinical Center

Bethesda, Maryland, 20892, United States

Location

Related Publications (3)

  • Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord. 1998;13 Suppl 3:2-23. doi: 10.1002/mds.870131303.

    PMID: 9827589BACKGROUND
  • Ni Z, Pinto AD, Lang AE, Chen R. Involvement of the cerebellothalamocortical pathway in Parkinson disease. Ann Neurol. 2010 Dec;68(6):816-24. doi: 10.1002/ana.22221.

    PMID: 21194152BACKGROUND
  • Pascual-Leone A, Valls-Sole J, Toro C, Wassermann EM, Hallett M. Resetting of essential tremor and postural tremor in Parkinson's disease with transcranial magnetic stimulation. Muscle Nerve. 1994 Jul;17(7):800-7. doi: 10.1002/mus.880170716.

    PMID: 8008009BACKGROUND

MeSH Terms

Conditions

Essential TremorTorticollisDystonic Disorders

Condition Hierarchy (Ancestors)

Movement DisordersCentral Nervous System DiseasesNervous System DiseasesDystoniaDyskinesiasNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Mark Hallett, M.D.

    National Institute of Neurological Disorders and Stroke (NINDS)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 2, 2017

First Posted

February 3, 2017

Study Start

April 7, 2017

Primary Completion

March 22, 2018

Study Completion

March 22, 2018

Last Updated

August 1, 2018

Record last verified: 2018-03

Locations